NIH-funded research P01 program project

Understanding how sickle cell disease affects bone marrow and blood cell production

Official title: Sickle cell bone marrow niche and regulation of platelet activation and erythropoiesis

Funded at New York Blood Center · NIH-11015294 · Data updated 2026-11-12

This project explores how sickle cell disease changes the bone marrow, which might help us understand why patients have issues with blood clotting and red blood cell production.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionNew York Blood Center
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 20, 2020
Project endJune 30, 2030
Funding year2025
Award (this year)$427,000
NIH project number2P01HL149626-06
Project IDNIH-11015294 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research is for patients with sickle cell disease who are interested in the underlying biological mechanisms of their condition.

Less likely to help

Patients seeking immediate new treatments or direct clinical intervention would not directly benefit from this basic science project.

What this research studies

In sickle cell disease, patients often have too many active platelets, which can lead to complications, and also struggle with anemia because their red blood cells are destroyed and not made properly. We believe that changes in the bone marrow, where blood cells are made, play a big role in these problems. Specifically, we are looking at how certain cells in the bone marrow, called Mesenchymal Stem Cells (MSCs), are affected by sickle cell disease and how this impacts the production of platelets and red blood cells. Our goal is to uncover the exact ways these bone marrow changes contribute to the disease, hoping to find new ways to help patients.

Why it matters

Potential benefit: If successful, this work could lead to new treatments that target the bone marrow to improve blood cell production and reduce harmful platelet activity in sickle cell disease.

How similar studies have gone: While the role of platelets and erythropoiesis in SCD is known, this specific focus on heme-driven alterations in MSCs within the bone marrow niche represents a novel approach.

Where this research is happening

  • New York Blood Center
    New York, United States
    Active

Researchers

  • Principal investigator: Su, Shan — New York Blood Center
  • Study coordinator: Su, Shan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.